Correlating EGFR Expression with Receptor-Binding Properties and Internalization of ⁶⁴Cu-DOTA-Cetuximab in 5 Cervical Cancer Cell Lines

Abstract

(64)Cu-DOTA-cetuximab was successfully used to detect and quantify EGFR expression in cervical cancer tumors, and small-animal PET/CT of EGFR-expressing CaSki tumors suggests potential for PET/CT of EGFR-positive tumors.